Spectrum Therapeutics Provides Update on its Global Clinical Research Program and Unveils Pharmacovigilance Program

New Cannabis Ventures
By NCV NewswireJun 5, 2019, 7:55 am210 pts
SMITHS FALLS, ON, June 5, 2019 /PRNewswire/ – Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines through clinical…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

PEI sold $26.4 million worth of cannabis in 2024-2025 79

Feds Propose Amending 2nd Amendment Ban for Cannabis Consumers, Others 78

It Was Not Great News 76

Medicaid coverage for CBD in limbo as Congress removes hemp THC protections from spending bill 74

Stop Flying Blind: Build a Cannabis Data Stack That Actually Works 71

The World’s First AI-Driven Cannabis Seed-Sorting System Is Here 70

Washington Bill To Let Seriously Ill Patients Use Medical Cannabis In Hospitals Advances 65

Medicaid coverage for CBD in limbo as Congress removes hemp THC protections from spending bill 59

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.